01 4Amgen Canada Inc.
01 22346996
02 22649292
01 4ROMIPLOSTIM
01 4POWDER FOR SOLUTION
01 22019-10-22
02 22027-04-20
Patent Expiration Date : 2019-10-22
Date Granted : 2013-11-19
Brand Name : NPLATE
Patent Number : 2346996
Filing Date : 1999-10-22
Strength per Unit : 250 ?g / 0.5 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2019-10-22
Date Granted : 2013-11-19
Patent Expiration Date : 2019-10-22
Date Granted : 2013-11-19
Brand Name : NPLATE
Patent Number : 2346996
Filing Date : 1999-10-22
Strength per Unit : 500 ?g / 1 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2019-10-22
Date Granted : 2013-11-19
Patent Expiration Date : 2027-04-20
Date Granted : 2017-01-17
Brand Name : NPLATE
Patent Number : 2649292
Filing Date : 2007-04-20
Strength per Unit : 250 ?g / 0.5 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-04-20
Date Granted : 2017-01-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-04-20
Date Granted : 2017-01-17
Brand Name : NPLATE
Patent Number : 2649292
Filing Date : 2007-04-20
Strength per Unit : 500 ?g / 1 mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2027-04-20
Date Granted : 2017-01-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
